Literature DB >> 9554892

Leukotriene modifiers in the treatment of asthma. Look promising across the board of asthma severity.

A Sampson, S Holgate.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9554892      PMCID： PMC1113026          DOI： 10.1136/bmj.316.7140.1257

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  16 in total

1.  Acute and chronic effects of a 5-lipoxygenase inhibitor in asthma: a 6-month randomized multicenter trial. Zileuton Study Group.

Authors:  M C Liu; L M Dubé; J Lancaster
Journal:  J Allergy Clin Immunol       Date:  1996-11       Impact factor: 10.793

Review 2.  Antileukotrienes in the treatment of asthma.

Authors:  P M O'Byrne; E Israel; J M Drazen
Journal:  Ann Intern Med       Date:  1997-09-15       Impact factor: 25.391

3.  Leukotriene C4 synthase promoter polymorphism and risk of aspirin-induced asthma.

Authors:  M Sanak; H U Simon; A Szczeklik
Journal:  Lancet       Date:  1997-11-29       Impact factor: 79.321

4.  Elevated levels of leukotriene C4 in bronchoalveolar lavage fluid from atopic asthmatics after endobronchial allergen challenge.

Authors:  S E Wenzel; G L Larsen; K Johnston; N F Voelkel; J Y Westcott
Journal:  Am Rev Respir Dis       Date:  1990-07

5.  Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma.

Authors:  A S Cowburn; K Sladek; J Soja; L Adamek; E Nizankowska; A Szczeklik; B K Lam; J F Penrose; F K Austen; S T Holgate; A P Sampson
Journal:  J Clin Invest       Date:  1998-02-15       Impact factor: 14.808

Review 6.  Leukotriene antagonists and synthesis inhibitors: new directions in asthma therapy.

Authors:  S T Holgate; P Bradding; A P Sampson
Journal:  J Allergy Clin Immunol       Date:  1996-07       Impact factor: 10.793

7.  Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription.

Authors:  K H In; K Asano; D Beier; J Grobholz; P W Finn; E K Silverman; E S Silverman; T Collins; A R Fischer; T P Keith; K Serino; S W Kim; G T De Sanctis; C Yandava; A Pillari; P Rubin; J Kemp; E Israel; W Busse; D Ledford; J J Murray; A Segal; D Tinkleman; J M Drazen
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

8.  Effectiveness of the leukotriene receptor antagonist zafirlukast for mild-to-moderate asthma. A randomized, double-blind, placebo-controlled trial.

Authors:  S Suissa; R Dennis; P Ernst; O Sheehy; S Wood-Dauphinee
Journal:  Ann Intern Med       Date:  1997-02-01       Impact factor: 25.391

9.  Urinary leukotriene E4 after antigen challenge and in acute asthma and allergic rhinitis.

Authors:  G W Taylor; I Taylor; P Black; N H Maltby; N Turner; R W Fuller; C T Dollery
Journal:  Lancet       Date:  1989-03-18       Impact factor: 79.321

Review 10.  Cysteinyl leukotrienes in asthma: old mediators up to new tricks.

Authors:  D W Hay; T J Torphy; B J Undem
Journal:  Trends Pharmacol Sci       Date:  1995-09       Impact factor: 14.819
View more
  10 in total

1.  Difficult asthma or Churg-Strauss syndrome?

Authors:  D P D'Cruz; N C Barnes; C M Lockwood
Journal:  BMJ       Date:  1999-02-20

2.  Variant LTC(4) synthase allele modifies cysteinyl leukotriene synthesis in eosinophils and predicts clinical response to zafirlukast.

Authors:  A P Sampson; S Siddiqui; D Buchanan; P H Howarth; S T Holgate; J W Holloway; I Sayers
Journal:  Thorax       Date:  2000-10       Impact factor: 9.139

3.  Eosinophilic oesophagitis: treatment using Montelukast.

Authors:  R Sinharay
Journal:  Gut       Date:  2003-08       Impact factor: 23.059

Review 4.  Fortnightly review: modern drug treatment of chronic asthma.

Authors:  B J Lipworth
Journal:  BMJ       Date:  1999-02-06

5.  Montelukast was inefficient in maintaining steroid-induced remission in adult eosinophilic esophagitis.

Authors:  Alfredo J Lucendo; Livia C De Rezende; Susana Jiménez-Contreras; Jose Luis Yagüe-Compadre; Jesús González-Cervera; Teresa Mota-Huertas; Danila Guagnozzi; Teresa Angueira; Sonia González-Castillo; Angel Arias
Journal:  Dig Dis Sci       Date:  2011-06-15       Impact factor: 3.199

Review 6.  Improving outcomes in elderly patients with asthma.

Authors:  D S Renwick; M J Connolly
Journal:  Drugs Aging       Date:  1999-01       Impact factor: 3.923

7.  KNOWLEDGE DRIVEN BINNING AND PHEWAS ANALYSIS IN MARSHFIELD PERSONALIZED MEDICINE RESEARCH PROJECT USING BIOBIN.

Authors:  Anna O Basile; John R Wallace; Peggy Peissig; Catherine A McCarty; Murray Brilliant; Marylyn D Ritchie
Journal:  Pac Symp Biocomput       Date:  2016

8.  Eosinophilic oesophagitis: a novel treatment using Montelukast.

Authors:  S E A Attwood; C J Lewis; C S Bronder; C D Morris; G R Armstrong; J Whittam
Journal:  Gut       Date:  2003-02       Impact factor: 23.059

9.  Effect of different monotherapies on serum nitric oxide and pulmonary functions in children with mild persistent asthma.

Authors:  Zeinab Mohamed Radwan; Gamal Abdel Nasser Yamamah; Hala Hamdy Shaaban; Azza Mohamed Omar Abdel-Rahman; Amany Abdel-Ghany Ismaeil; Elham Mohamed Mostafa
Journal:  Arch Med Sci       Date:  2010-12-29       Impact factor: 3.318

10.  Eosinophilic gastrointestinal diseases: review and update.

Authors:  Mahreema Jawairia; Ghulamullah Shahzad; Paul Mustacchia
Journal:  ISRN Gastroenterol       Date:  2012-06-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.